Liver TransplantationPub Date : 2025-06-01Epub Date: 2025-01-31DOI: 10.1097/LVT.0000000000000579
Nicole M Loo, Andrew P Keaveny
{"title":"After the curtain was raised, hepatitis C plays on: Celebrities and hepatitis C.","authors":"Nicole M Loo, Andrew P Keaveny","doi":"10.1097/LVT.0000000000000579","DOIUrl":"10.1097/LVT.0000000000000579","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"842-843"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143066519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2024-08-23DOI: 10.1097/LVT.0000000000000454
Sara Hassan, Ahmad Anouti, Queenie K G Tan, Kirk Wangensteen, Amal Aqul
{"title":"Liver transplantation for pediatric genetic and metabolic disorders.","authors":"Sara Hassan, Ahmad Anouti, Queenie K G Tan, Kirk Wangensteen, Amal Aqul","doi":"10.1097/LVT.0000000000000454","DOIUrl":"10.1097/LVT.0000000000000454","url":null,"abstract":"<p><p>Pediatric genetic and metabolic liver diseases comprise a broad spectrum of conditions and represent the second most common indication for liver transplantation following biliary atresia. The decision to transplant can be challenging and requires consideration of several factors, including hepatic involvement, extrahepatic manifestations, and anticipated posttransplant outcomes. This review examines pediatric genetic and metabolic liver diseases, their pathophysiology, clinical presentation, and the role of liver transplantation.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"803-814"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2024-11-20DOI: 10.1097/LVT.0000000000000539
Marie-Josée Lynch, Lauren Carrique, Christian S Hendershot, Hannah Wozniak, Vathany Kulasingam, Bernard Le Foll, Caitlin Don, Susan Abbey, Isabel Sales, Les Lilly, Mamatha Bhat, Cynthia Tsien, Adrienne Tan, Dilip Koshy, Nazia Selzner
{"title":"Utilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease.","authors":"Marie-Josée Lynch, Lauren Carrique, Christian S Hendershot, Hannah Wozniak, Vathany Kulasingam, Bernard Le Foll, Caitlin Don, Susan Abbey, Isabel Sales, Les Lilly, Mamatha Bhat, Cynthia Tsien, Adrienne Tan, Dilip Koshy, Nazia Selzner","doi":"10.1097/LVT.0000000000000539","DOIUrl":"10.1097/LVT.0000000000000539","url":null,"abstract":"<p><p>Although a set period of abstinence is no longer a requirement for transplant consideration in many liver transplantation programs, it is imperative to use valid monitoring tools to detect ongoing alcohol use in candidates for transplant. Urinary ethyl glucuronide (EtG) is an objective measure of alcohol use. This single-center retrospective study aims to describe the psychosocial characteristics of patients with alcohol-associated liver disease (ALD) who provided positive EtG tests in the pretransplant phase. Data were collected between May 1, 2018, and November 30, 2021, for all patients with ALD referred to our transplantation program (n = 497). Psychosocial characteristics and transplant outcomes were recorded for all patients. Patients with a positive EtG test were compared to patients who did not have a positive EtG test. A backward logistic regression analysis was performed to assess the factors associated with a positive EtG test. Of the 497 patients evaluated, 40 (8%) provided a positive EtG test, including at the initial clinic visit (n = 20), during medical evaluation (n = 14), and while on the waitlist (n = 6). Severe alcohol use disorder ( p < 0.01), consuming <10 daily standard drinks ( p = 0.011), and longer duration of daily alcohol use ( p = 0.028) were significantly associated with a positive EtG test. Psychiatric comorbidity and previous treatment for alcohol use disorder were not significantly associated with positive tests. A minority of patients with ALD provided a positive urine EtG in the pretransplant phase. Alongside clinical interviews, biomarker testing is an objective tool to identify ongoing alcohol use in patients with ALD.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"762-769"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2025-02-03DOI: 10.1097/LVT.0000000000000582
Hanwen Yang, Yujun Zhao
{"title":"Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury-Exacerbation or mitigation?","authors":"Hanwen Yang, Yujun Zhao","doi":"10.1097/LVT.0000000000000582","DOIUrl":"10.1097/LVT.0000000000000582","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"E24"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143066527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2025-03-26DOI: 10.1097/LVT.0000000000000614
Shannon Zielsdorf, Alejandro Torres Hernandez, Blayne Amir Sayed
{"title":"PRO: All pediatric transplant centers should have LDLT as an option.","authors":"Shannon Zielsdorf, Alejandro Torres Hernandez, Blayne Amir Sayed","doi":"10.1097/LVT.0000000000000614","DOIUrl":"10.1097/LVT.0000000000000614","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"832-835"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2025-03-26DOI: 10.1097/LVT.0000000000000613
N Thao N Galvan, Abbas Rana, John A Goss
{"title":"CON: LDLT should not be a requirement for pediatric transplant programs.","authors":"N Thao N Galvan, Abbas Rana, John A Goss","doi":"10.1097/LVT.0000000000000613","DOIUrl":"10.1097/LVT.0000000000000613","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"836-839"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2025-06-01Epub Date: 2024-11-12DOI: 10.1097/LVT.0000000000000536
Spencer C Harris, Sarmed Al-Yassin, Rahul B Chaudhari, Mary Leslie Gallagher, Brian C Davis, Zenaida Malpaya, Puneet Puri, Joelle Lemmons, Michael Fuchs, Jasmohan S Bajaj
{"title":"Tobacco use, cirrhosis, and age are predictors of readiness to change and continued drinking following brief alcohol intervention in veterans.","authors":"Spencer C Harris, Sarmed Al-Yassin, Rahul B Chaudhari, Mary Leslie Gallagher, Brian C Davis, Zenaida Malpaya, Puneet Puri, Joelle Lemmons, Michael Fuchs, Jasmohan S Bajaj","doi":"10.1097/LVT.0000000000000536","DOIUrl":"10.1097/LVT.0000000000000536","url":null,"abstract":"<p><p>Alcohol use disorder is prevalent within the Veterans Health System, especially in patients being seen in hepatology clinics, and needs a point-of-care strategy. A brief alcohol intervention based on AUDIT-C (Alcohol Use Disorders Identification Test) may be needed for the management of hazardous alcohol intake, but feasibility is unclear. We aimed to define predictors of readiness to cease alcohol intake (0-10, 10 being ready to quit now) and continued drinking after using a brief alcohol intervention in veterans seen in hepatology clinics cross-sectionally and longitudinally over 6 months. A total of 414 men with liver disease (average age of 61 y old, 48% with cirrhosis, 31% with concomitant psychiatric conditions, 44% with tobacco use, and 14% with prior alcohol use disorder therapy) were approached. One hundred forty-four patients (35%) had a positive AUDIT-C (8.9 ± 4.0) and were given the brief intervention. Eighty of these patients (56%) had a high readiness to change, listing \"wanting to improve health\" and \"prior success at reducing alcohol intake\" as their most frequent reasons. On regression analysis, concomitant tobacco use was associated with a significantly lower readiness to quit alcohol score. On longitudinal follow-up at 6 months, 34 (23%) patients were still drinking. These patients were older and more likely to have concomitant diagnoses of cirrhosis and anxiety. Overall, we found that in a large cohort of veterans seen in hepatology clinics in routine practice, a brief intervention targeted at alcohol use is feasible. Older patients with concomitant tobacco use, cirrhosis, and anxiety may need more longitudinal attention to ensure that the initial interest in reducing problem drinking is sustained.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"709-715"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety.","authors":"Jiahao Li, Meiting Qin, Yunhua Tang, Jia Dan, Honghui Chen, Huadi Chen, Jinbo Huang, Yongqi Yang, Tielong Wang, Yefu Li, Maogen Chen, Weiqiang Ju, Dongping Wang, Zhiyong Guo, Haidong Tan, Xiaoshun He, Qiang Zhao","doi":"10.1097/LVT.0000000000000545","DOIUrl":"10.1097/LVT.0000000000000545","url":null,"abstract":"<p><p>Conventional ischemia-free liver transplantation (CIFLT) represents a pioneering procedure that circumvents ischemia-reperfusion injury to livers throughout the transplant procedure. However, its complexity has limited its widespread adoption. This study introduced a simplified ischemia-free liver transplantation (SIFLT) technique by providing an alternating flow of the portal vein and hepatic artery, demonstrating its efficacy and safety. In this retrospective study, 32 patients who received SIFLT and 32 who received CIFLT were included between January 2021 and January 2024. The intraoperative and postoperative outcomes were collected and elevated. Patients who underwent SIFLT had a shorter anhepatic phase (44.0±2.4 vs. 51.6±2.4 min, p =0.03), along with a comparatively reduced intraoperative blood loss compared to those who underwent CIFLT. Furthermore, the SIFLT group exhibited significantly lower peak AST levels within postoperative 7 days (413.1±62.6 vs. 707.5±110.7 U/L, p =0.02). The incidence of early allograft dysfunction, primary nonfunction, and transplant-related complications were similar across both groups. There were no significant differences in the number of Clavien-Dindo classification of surgical complications and comprehensive complication index at 3 months after transplantation. Kaplan-Meier analysis confirmed similar patient and graft survival rates. The subgroup analysis of extended criteria donor demonstrated that SIFLT can effectively reduce anhepatic phase and intraoperative blood loss and can achieve a clinical prognosis similar to CIFLT. Additionally, histological analysis revealed that both groups demonstrated well-preserved livers and bile ducts. The SIFLT simplifies the intricate surgical procedure while ensuring the protection of livers from ischemia-reperfusion injury. This technique holds promise for enabling patients to achieve clinical outcomes comparable to those of CIFLT.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"737-749"},"PeriodicalIF":4.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}